"By teaming up with experts with a range of experience, we will be able to translate our findings to the clinic much faster. I’m more optimistic than ever before."
— Dr. Christopher Kemp
/content/dam/www/people-profile-photos/k/christopher-kemp/christopher-kemp-d.jpg
Kemp
Christopher Kemp, PhD
- Professor, Human Biology Division, Fred Hutch
- Professor, Public Health Sciences Division, Fred Hutch
- Member, Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch
- Affiliate Investigator, Clinical Research Division, Fred Hutch
- Affiliate Professor, Pathology, University of Washington School of Medicine
Background
Dr. Christopher Kemp works to make the promise of precision oncology a reality. His goal is to develop targeted therapies — treatments that not only target a specific individual’s tumors, but that target tumors while sparing healthy tissue. He and his team have developed an approach to identify the next generation of precision cancer therapeutics that draws on patient tumor samples. It integrates molecular information from tumor genomics with cancer cell’s sensitivity to potential drugs. The team is applying the strategy to cancers including pancreatic, ovarian, breast, and head and neck cancer. Dr. Kemp is a member of the Cancer Target Discovery and Development Network, a multi-institutional collaborative effort designed to bridge the knowledge gap between cancer genomics and precision oncology.
Education
PhD, Oncology, University of Wisconsin-Madison, 1989
MS, Fisheries Science, Oregon State University, 1984
BA, Biology, Case Western Reserve University, 1980